CDLX insider sales and restricted stock vesting

Cardlytics insider transactions reported.

Rhea-AI Filing Summary

Cardlytics insider transactions reported. Amit Gupta reported sales of 5,807 common shares on 01/05/2026 and 52,049 common shares on 02/17/2026. The filing also lists restricted stock vesting of 45,159 shares on 02/13/2026 attributable to issuer compensation.

The transactions are recorded as routine insider activity: two past sales over the prior three months and an issuer vesting event. The filing shows numbers and dates for each item but does not state proceeds recipients beyond the named reporting person.

Insights

Corporate Governance & Insider Transactions

Insider reported multiple sales and a vesting event; activity appears routine.

The filing lists two sales by Amit Gupta — 5,807 shares on 01/05/2026 and 52,049 shares on 02/17/2026 — and a separate issuer-reported restricted stock vesting of 45,159 shares on 02/13/2026. These entries conform to standard disclosure of completed sales and compensation-related vesting.

Cash-flow treatment for the sales and any intended disposition methods are not detailed in the excerpt. Subsequent filings or broker reports would show sale prices and proceeds; timing and strategic intent are not disclosed here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CDLX report?

The filing shows Amit Gupta sold 5,807 shares on 01/05/2026 and 52,049 shares on 02/17/2026. It also records issuer-reported restricted stock vesting of 45,159 shares on 02/13/2026.

How many shares vested for CDLX and when?

The document lists 45,159 restricted shares vesting on 02/13/2026 as an issuer compensation event. The vesting is recorded under securities to be sold/issued and tied to that specific date.

Who reported the sales in the CDLX Form 144?

The sales are reported under the name Amit Gupta with an address in Atlanta, GA. The filing attributes the two sale entries and the reporting name for those transactions in the past three months.

Do the filings show sale proceeds for CDLX insider sales?

The excerpt lists share counts and dates for the sales (5,807 and 52,049) but does not provide sale prices or aggregate proceeds in the visible content. Price and proceeds details are not shown in this excerpt.

Does the Form 144 indicate who received proceeds from the sales?

The filing names the reporting person for the sales but does not state who received proceeds beyond that attribution. The entry format records transactions and dates without specifying the recipient of cash in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001961238
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cardlytics, Inc.
SEC File Number	001-38386
Address of Issuer	675 PONCE DE LEON AVENUE, NE SUITE 4100 ATLANTA GEORGIA 30308
Phone	888-798-5802
Name of Person for Whose Account the Securities are To Be Sold	Gupta Amit
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	45159	41826.27	54056548	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			45159	02/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Amit Gupta 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	01/05/2026	5807	6795.93
Amit Gupta 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	02/17/2026	52049	46969.02

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Amit Gupta
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)